17-39408596-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004774.4(MED1):āc.3625A>Gā(p.Met1209Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000378 in 1,614,146 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00013 ( 0 hom., cov: 31)
Exomes š: 0.000028 ( 0 hom. )
Consequence
MED1
NM_004774.4 missense
NM_004774.4 missense
Scores
3
16
Clinical Significance
Conservation
PhyloP100: 3.90
Genes affected
MED1 (HGNC:9234): (mediator complex subunit 1) The activation of gene transcription is a multistep process that is triggered by factors that recognize transcriptional enhancer sites in DNA. These factors work with co-activators to direct transcriptional initiation by the RNA polymerase II apparatus. The protein encoded by this gene is a subunit of the CRSP (cofactor required for SP1 activation) complex, which, along with TFIID, is required for efficient activation by SP1. This protein is also a component of other multisubunit complexes e.g. thyroid hormone receptor-(TR-) associated proteins which interact with TR and facilitate TR function on DNA templates in conjunction with initiation factors and cofactors. It also regulates p53-dependent apoptosis and it is essential for adipogenesis. This protein is known to have the ability to self-oligomerize. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.13439497).
BS2
High AC in GnomAd4 at 20 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MED1 | NM_004774.4 | c.3625A>G | p.Met1209Val | missense_variant | 17/17 | ENST00000300651.11 | NP_004765.2 | |
MED1 | XM_047436314.1 | c.3109A>G | p.Met1037Val | missense_variant | 13/13 | XP_047292270.1 | ||
MED1 | XM_047436315.1 | c.2968A>G | p.Met990Val | missense_variant | 9/9 | XP_047292271.1 | ||
MED1 | XM_006721957.3 | c.1640+1985A>G | intron_variant | XP_006722020.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MED1 | ENST00000300651.11 | c.3625A>G | p.Met1209Val | missense_variant | 17/17 | 1 | NM_004774.4 | ENSP00000300651.6 | ||
MED1 | ENST00000394287.7 | c.1640+1985A>G | intron_variant | 1 | ENSP00000377828.3 | |||||
MED1 | ENST00000577831.5 | n.*3198A>G | non_coding_transcript_exon_variant | 16/16 | 2 | ENSP00000463307.1 | ||||
MED1 | ENST00000577831.5 | n.*3198A>G | 3_prime_UTR_variant | 16/16 | 2 | ENSP00000463307.1 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152136Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
20
AN:
152136
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000517 AC: 13AN: 251456Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135902
GnomAD3 exomes
AF:
AC:
13
AN:
251456
Hom.:
AF XY:
AC XY:
4
AN XY:
135902
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000280 AC: 41AN: 1461892Hom.: 0 Cov.: 35 AF XY: 0.0000275 AC XY: 20AN XY: 727246
GnomAD4 exome
AF:
AC:
41
AN:
1461892
Hom.:
Cov.:
35
AF XY:
AC XY:
20
AN XY:
727246
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000131 AC: 20AN: 152254Hom.: 0 Cov.: 31 AF XY: 0.000148 AC XY: 11AN XY: 74450
GnomAD4 genome
AF:
AC:
20
AN:
152254
Hom.:
Cov.:
31
AF XY:
AC XY:
11
AN XY:
74450
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
4
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
6
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 05, 2024 | The c.3625A>G (p.M1209V) alteration is located in exon 17 (coding exon 17) of the MED1 gene. This alteration results from a A to G substitution at nucleotide position 3625, causing the methionine (M) at amino acid position 1209 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
N
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Uncertain
D
Sift4G
Benign
T
Polyphen
B
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at